These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24994553)

  • 1. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
    J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
    Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
    Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
    Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
    Zhang XY; Zhang WF; Zhou DF; Chen DC; Xiu MH; Wu HR; Haile CN; Kosten TA; Kosten TR
    Biol Psychiatry; 2012 Oct; 72(8):700-6. PubMed ID: 22695185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
    Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
    Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
    Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
    Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
    Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.
    Zhen YF; Zhang J; Liu XY; Fang H; Tian LB; Zhou DH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2013 May; 227(1):93-100. PubMed ID: 23263460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
    Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.